What is Dorsata?
Founded in 2011 and headquartered in Arlington, Virginia, Dorsata operates within the healthcare technology landscape, focusing on optimizing workflows for Obstetrics and Gynecology (Ob-Gyn) practices. The company's software solutions are designed to streamline administrative and clinical processes, aiming to improve efficiency and patient care within specialized medical fields. Dorsata's strategic positioning in a niche but critical segment of healthcare IT suggests a focused approach to addressing specific industry pain points.
How much funding has Dorsata raised?
Dorsata has raised a total of $6.3M across 2 funding rounds:
Angel/Seed
$1.1M
Series A
$5.2M
Angel/Seed (2016): $1.1M with participation from QED Investors, Partnership Fund for New York City, and 1776 Ventures
Series A (2020): $5.2M led by Fool Ventures, Gore Range Capital, Women’s Health USA, LabCorp, and QED Investors
Key Investors in Dorsata
LabCorp
Labcorp Holdings Inc. is a prominent laboratory services company providing vital information for healthcare decisions. Its extensive diagnostic and biopharma services, including specialized testing for women's health, align with Dorsata's focus on the Ob-Gyn sector.
QED Investors
QED Investors is a venture capital firm specializing in early-stage, disruptive financial services companies. Their investment in Dorsata suggests a belief in the company's disruptive potential within the healthcare software market, potentially leveraging their expertise in scaling innovative businesses.
Partnership Fund for New York City
The Partnership for New York City is an organization that mobilizes the private sector to foster economic opportunity and innovation. Their involvement indicates support for Dorsata's growth and its potential contribution to the innovation ecosystem.
What's next for Dorsata?
With the recent influx of major strategic investment, Dorsata is poised for accelerated growth and market expansion. The company is likely to leverage this capital to enhance its product offerings, scale its operations, and potentially broaden its reach within the healthcare provider network. Further development of its Ob-Gyn workflow solutions, coupled with strategic partnerships, will be key to solidifying its market position and driving future innovation in health tech. The company's trajectory indicates a move towards scaling its established solutions and exploring new avenues for technological advancement in women's health.
See full Dorsata company page
